Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein
- PMID: 20399232
- DOI: 10.1016/j.jviromet.2010.04.003
Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein
Abstract
The dengue virus NS1 protein has been shown to be a protective antigen under different experimental conditions but the recombinant protein produced in bacterial expression systems is usually not soluble and loses structural and immunological features of the native viral protein. In the present study, experimental conditions leading to purification and refolding of the recombinant dengue virus type 2 (DENV-2) NS1 protein expressed in Escherichia coli are described. The refolded recombinant protein was recovered as heat-stable soluble dimers with preserved structural features, as demonstrated by spectroscopic methods. In addition, antibodies against epitopes of the NS1 protein expressed in eukaryotic cells recognized the refolded protein expressed in E. coli but not the denatured form or the same protein submitted to a different refolding condition. Collectively, the results demonstrate that the recombinant NS1 protein preserved important conformation and antigenic determinants of the native virus protein and represents a valuable reagent either for the development of vaccines or for diagnostic methods.
Copyright (c) 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Polyclonal antibodies against properly folded Dengue virus NS1 protein expressed in E. coli enable sensitive and early dengue diagnosis.J Virol Methods. 2011 Jul;175(1):109-16. doi: 10.1016/j.jviromet.2011.04.029. Epub 2011 May 4. J Virol Methods. 2011. PMID: 21569796
-
High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen.J Med Virol. 2001 Nov;65(3):553-60. J Med Virol. 2001. PMID: 11596093
-
Circulating human antibodies against dengue NS1 protein: potential of recombinant D2V-NS1 proteins in diagnostic tests.J Clin Virol. 2005 Apr;32(4):305-12. doi: 10.1016/j.jcv.2004.08.015. J Clin Virol. 2005. PMID: 15780810
-
[Research progress in the structure and function of dengue virus non-structural 1 protein].Bing Du Xue Bao. 2014 Nov;30(6):683-8. Bing Du Xue Bao. 2014. PMID: 25868284 Review. Chinese.
-
Structural biology of flavivirus NS1 protein and its antibody complexes.Antiviral Res. 2024 Jul;227:105915. doi: 10.1016/j.antiviral.2024.105915. Epub 2024 May 20. Antiviral Res. 2024. PMID: 38777094 Review.
Cited by
-
Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli.Vaccines (Basel). 2020 Aug 31;8(3):492. doi: 10.3390/vaccines8030492. Vaccines (Basel). 2020. PMID: 32878023 Free PMC article. Review.
-
Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.Virus Genes. 2014 Oct;49(2):185-95. doi: 10.1007/s11262-014-1087-3. Epub 2014 May 23. Virus Genes. 2014. PMID: 24854144
-
Production of recombinant nonstructural 1 protein in Escherichia coli for early detection of Japanese encephalitis virus infection.Microb Biotechnol. 2012 Sep;5(5):599-606. doi: 10.1111/j.1751-7915.2012.00344.x. Epub 2012 Mar 27. Microb Biotechnol. 2012. PMID: 22452851 Free PMC article.
-
Recent Developments in Recombinant Protein-Based Dengue Vaccines.Front Immunol. 2018 Aug 23;9:1919. doi: 10.3389/fimmu.2018.01919. eCollection 2018. Front Immunol. 2018. PMID: 30190720 Free PMC article. Review.
-
Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of Response Surface Methodology.AMB Express. 2019 Dec 31;10(1):1. doi: 10.1186/s13568-019-0926-y. AMB Express. 2019. PMID: 31893321 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources